These cells express the antigen-presenting major histocompatibility complex II (MHCII) mostly on the villi, but in IBD, MHCII is instead upregulated in the small intestinal crypts, a change mostly driven by IFN-γ [12, 13]. Here, IFNG is linked to inflammatory bowel disease.